Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 06/01/18
Due: 06/01/19
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 01/20/23
End: 06/30/25
Due: 06/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom | NCT03368274 | Wen Zhang | user2@example.com | None | 2017-09-01 | 2018-06-01 | 2019-06-01 | - | - | 2025-07-14 |
| Short-term Glucocorticoid Combined with MMF for IgG4-RD | NCT06663618 | Wen Zhang | user2@example.com | None | 2023-09-01 | 2025-09-01 | 2026-09-01 | - | - | 2025-07-14 |
| Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD | NCT05781516 | Wen Zhang | user2@example.com | None | 2023-01-20 | 2025-06-30 | 2026-06-30 | - | - | 2025-07-14 |